Evaluation of Molecular Simulations and Deep Learning Prediction of Antibodies' Recognition of TRBC1 and TRBC2

Xincheng Zeng1, Tianqun Wang2, Yue Kang2

  • 1Engineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.

PubMed

Insights

This study quantifies antibody affinity differences for T cell receptor β-chain constant (TRBC) targets TRBC1 and TRBC2 using AI and molecular simulations. Findings aid in developing precise cancer therapies that selectively eliminate malignant T cells.

Area of Science:

  • Immunology
  • Computational Biology
  • Structural Biology

Background:

  • T cell receptor β-chain constant (TRBC) proteins, TRBC1 and TRBC2, are homologous cancer targets.
  • Targeted antibody therapeutics aim to eradicate malignant T cells while preserving normal T cells.

Purpose of the Study:

  • To quantify affinity differences in mutated antibodies against TRBC1 and TRBC2.
  • To explore antibody-antigen recognition mechanisms using advanced computational methods.

Main Methods:

  • Utilized molecular simulations and artificial intelligence (AI) to assess antibody affinity.
  • Employed Free Energy Perturbation (FEP) calculations for affinity verification.
  • Conducted long-time molecular dynamics simulations to analyze antigen recognition dynamics.

Main Results:

  • Quantified affinity variations in antibodies with specific mutations for TRBC1 and TRBC2.
  • Validated AI-predicted affinities using FEP calculations.
  • Revealed dynamic mechanisms of TRBC antibody-antigen interactions.

Conclusions:

  • AI and molecular simulations effectively quantify antibody affinity for TRBC targets.
  • Understanding dynamic recognition mechanisms can guide the design of improved TRBC-targeted antibody therapies for cancer.

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...